BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31743242)

  • 1. Perspiration interventions for conservative management of kidney disease and uremia.
    Keller RW; Kopple JD; Kalantar-Zadeh K
    Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):57-63. PubMed ID: 31743242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel conservative management of chronic kidney disease via dialysis-free interventions.
    Zarantonello D; Rhee CM; Kalantar-Zadeh K; Brunori G
    Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):97-107. PubMed ID: 33186220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal dialysis for conservative management of Uremia.
    Puri I; Shirazi NM; Yap E; Saggi SJ
    Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):64-70. PubMed ID: 31725008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep disorders in end-stage renal disease: 'Markers of inadequate dialysis'?
    Perl J; Unruh ML; Chan CT
    Kidney Int; 2006 Nov; 70(10):1687-93. PubMed ID: 16969388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conductive Thread-Based Textile Sensor for Continuous Perspiration Level Monitoring.
    Jia J; Xu C; Pan S; Xia S; Wei P; Noh HY; Zhang P; Jiang X
    Sensors (Basel); 2018 Nov; 18(11):. PubMed ID: 30400608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dilemmas of patient treatment for end-stage renal disease.
    Schmidt RW; Blumenkrantz M; Wiegmann TB
    Am J Kidney Dis; 1983 Jul; 3(1):37-47. PubMed ID: 6346866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Options in uraemia therapy for diabetics with end-stage renal disease.
    Polenaković MH
    Prilozi; 2004; 25(1-2):27-51. PubMed ID: 15735534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secretory performance of eccrine sweat glands from the nephrologic viewpoint].
    Koban F; Hornak H; Schubert E; Rose W
    Z Gesamte Inn Med; 1987 May; 42(9):242-5. PubMed ID: 3630292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Care of the diabetic patient with end-stage renal disease.
    Markell MS; Friedman EA
    Semin Nephrol; 1990 May; 10(3):274-86. PubMed ID: 2190284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uremic pericarditis, pericardial effusion, and constrictive pericarditis in end-stage renal disease: Insights and pathophysiology.
    Rehman KA; Betancor J; Xu B; Kumar A; Rivas CG; Sato K; Wong LP; Asher CR; Klein AL
    Clin Cardiol; 2017 Oct; 40(10):839-846. PubMed ID: 28873222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision-making for people with dementia and advanced kidney disease: a secondary qualitative analysis of interviews from the Conservative Kidney Management Assessment of Practice Patterns Study.
    Scott J; Owen-Smith A; Tonkin-Crine S; Rayner H; Roderick P; Okamoto I; Leydon G; Caskey F; Methven S
    BMJ Open; 2018 Nov; 8(11):e022385. PubMed ID: 30420346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aspects of the physiopathology and therapy of arterial hypertension in "terminal" chronic uremia].
    Albertazzi A; Bugiardini G; Pallotti G; Putti C; Scolari P
    Bull Sci Med (Bologna); 1971; 143(2):139-42. PubMed ID: 5113531
    [No Abstract]   [Full Text] [Related]  

  • 13. Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia?
    Nishizawa Y; Shoji T; Ishimura E; Inaba M; Morii H
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S4-7. PubMed ID: 11576913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of peritoneal dialysis in the treatment of uremia.
    Ronco C; Dell'Aquila R; Rodighiero MP; Di Loreto P; Spanò E
    Contrib Nephrol; 2006; 150():226-234. PubMed ID: 16721014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative management and health-related quality of life in end-stage renal disease: a systematic review.
    Tsai HB; Chao CT; Chang RE; Hung KY; COGENT Study Group
    Clin Invest Med; 2017 Jun; 40(3):E127-E134. PubMed ID: 28653614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of End-Stage Renal Disease Patients with Advanced Uremia and Acidemia.
    Rehman IU; Idrees MK; Shoukat
    J Coll Physicians Surg Pak; 2016 Jan; 26(1):31-5. PubMed ID: 26787028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis prescription and kinetics in acute renal failure.
    Clark WR; Mueller BA; Kraus MA; Macias WL
    Adv Ren Replace Ther; 1997 Apr; 4(2 Suppl 1):64-71. PubMed ID: 9113242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of end-stage renal disease in Iran: a review article.
    Mousavi SS; Soleimani A; Mousavi MB
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):697-702. PubMed ID: 24821181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Hemodialysis Compared With Conservative Management on Quality of Life in Older Adults With End-Stage Renal Disease: Systematic Review.
    Eckert K; Motemaden L; Alves M
    J Hosp Palliat Nurs; 2018 Jun; 20(3):279-285. PubMed ID: 30063679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: has the outcome changed in the 1990s?
    Ifudu O; Mayers JD; Matthew JJ; Macey LJ; Brezsnyak W; Reydel C; McClendon E; Surgrue T; Rao TK; Friedman EA
    Am J Kidney Dis; 1997 Apr; 29(4):549-52. PubMed ID: 9100043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.